New research being presented at the European Congress on Obesity (ECO) in Venice, Italy (12-15 May), and published in the International Journal of Obesity, could help explain why type 2 diabetes is ...

Type 1 diabetes (T1D) is an autoimmune condition where the immune system destroys insulin-producing β-cells in the pancreas. Yet, not all patients lose insulin function at the same pace. Understanding ...

NEW YORK (Reuters Health) - Sedentary older people at risk of developing diabetes showed significant improvement in the function of their insulin-making beta cells after just one week of exercise, ...

Adrenomedullin disrupts insulin signaling in blood vessels, leading to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study by a team at the Max Planck Institute ...

Hormones are chemical messages that send signals throughout the body. They work slowly and affect body growth, development, metabolism, sexual function, mood, and other functions. Many medications are ...

Objective—To evaluate the extent of pancreatic β-cell function in a large number of insulin-dependent diabetic patients with a disease duration of 50 years or longer (Medalists). Research design and ...

New research could explain why diabetes drugs which have worked in animal experiments are not equally successful in humans. The researchers discovered differences -- but also unknown similarities - in ...

Much ado has been made of the neuronal damage inflicted by aggregates of tau, but what about the cost of losing normal tau protein to these proteopathic snarls? In the June 26 Journal of Experimental ...

Researchers identify genetic markers that predict the rate of β-cell failure in type 1 diabetes, facilitating earlier, personalized care strategies Type 1 diabetes (T1D) is an autoimmune condition ...